142nd APHA Annual Meeting and Exposition

Home Events & Meetings Annual Meeting Schedule & Program

Online Program

Annual Meeting Recordings are now available for purchase

310452
Academic-public partnerships: A new paradigm for diabetes research and practice

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014

Emily Laflamme, MPH , Chicago Department of Public Health, Chicago, IL
Elbert S. Huang, MD , Biological Sciences Division, Medicine, General Internal Medicine, University of Chicago, Chicago, IL
Arshiya Baig, MD, MPH , University of Chicago Department of Medicine, Chicago, IL
Monica E. Peek, MD, MPH , Department of Medicine, Section of General Internal Medicine, The University of Chicago, Chicago, IL
Deborah Burnet, MD, MA , General Internal Medicine, University of Chicago, Chicago, IL
Marshall H. Chin, MD, MPH , Department of Medicine, Section of General Internal Medicine, University of Chicago, Chicago, IL
Arlene Hankinson, MD MS , Chicago Department of Public Health, Chicago, IL
Kirsti Bocskay, PhD, MPH , Chicago Department of Public Health, Chicago, IL
Jay Bhatt, DO, MPH, MPA, FACP , Chicago Department of Public Health, Chicago, IL
Bechara Choucair, MD , Chicago Department of Public Health, Chicago, IL
According to the 2012 Behavioral Risk Factor Surveillance System, 8.1% of Chicago adults are estimated to have diabetes, disproportionately affecting some socio-demographic groups. As diabetes is a public health priority with complex prevention and management concerns, the Chicago Department of Public Health (CDPH) formed a partnership in 2011 with the University of Chicago Center for Diabetes Translation Research (CCDTR), focused on diabetes prevention and improving the quality of diabetes care, one of the few partnerships of its kind among Diabetes Translation Research Programs.

This robust relationship allows for sharing of expertise to achieve health outcomes, including reduction in rates of negative behavioral risk factors, diabetes incidence and diabetes-related complications, and process outcomes, including creation and evaluation of policy, developing and sharing datasets and expanding a strong partnership network. Through shared vision, the CCDTR-CDPH group has identified high-impact research priorities that have potential to be translated into practice. In 2014, CDPH will launch a novel, city-wide health survey, allowing researchers to investigate the effect of the Affordable Care Act on diabetes management and care. Additionally, our team is evaluating the impact of new school physical education policies on diabetes precursors in children. Finally, through data sharing and neighborhood geocoding, we are able to measure disparities in Type 2 and gestational diabetes more accurately and develop targeted interventions to address them. This poster will discuss how the collaborative, practice-oriented and academically rigorous nature of this partnership provides a framework for innovative and impactful diabetes research and practice.

Learning Areas:

Chronic disease management and prevention
Conduct evaluation related to programs, research, and other areas of practice
Program planning
Provision of health care to the public

Learning Objectives:
Identify strengths of academic-public partnerships in reducing incidence of diabetes and diabetes-related complications. Discuss how academic-public partnerships can benefit from shared expertise and resources to create and evaluate policy, develop new data sets and form partnership networks to influence diabetes prevention and management.

Keyword(s): Chronic Disease Prevention, Partnerships

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the principal investigator of the federally funded grant that supports the diabetes prevention and management work described in this abstract.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 3188.0: Poster Session I